Shan Xiong
Research Subjects
Shan Xiong has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Limin Xie
National Clinical Research Center for Metabolic Diseases, Department of Metabolism and Endocrinology
1 shared publication - Tuo Deng
National Clinical Research Center for Metabolic Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China
1 shared publication - Wei Liu
Department of Hepatobiliary and Pancreatic Surgery and metabolic surgery, The Second Xiangya Hospital of Central South University, Changsha, China
1 shared publication - Yaqi Peng
National Clinical Research Center for Metabolic Diseases, Department of Metabolism and Endocrinology
1 shared publication - Yihang Wang
National Clinical Research Center for Metabolic Diseases, Department of Metabolism and Endocrinology
1 shared publication - Ying Mei
National Clinical Research Center for Metabolic Diseases, Department of Metabolism and Endocrinology
1 shared publication
Latest Publications
- Open Access
- 4 March 2024
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (6) , 3778-3794
The effect of omentoplasty in various surgical operations: systematic review and meta-analysis
Background: Omentoplasty is commonly used in various surgeries. However, its effectiveness is unsure due to lack of convincing data and research. To clarify the impact of omentoplasty on postoperative complications of various procedures, this systematic review and meta-analysis was performed. Methods: A systematic review of published literatures from four databases: PubMed, Web of Science, Cochrane Library, and Embase before 14 July 2022. The authors primarily included publications on five major surgical operations performed in conjunction with omentoplasty: thoracic surgery, esophageal surgery, gastrointestinal surgery, pelvi-perineal surgery, and liver surgery. The protocol was registered in PROSPERO. Results: This review included 25 273 patients from 91 studies (n=9670 underwent omentoplasty). Omentoplasty was associated with a lower risk of overall complications particularly in gastrointestinal [relative risk (RR) 0.53; 95% CI: 0.39–0.72] and liver surgery (RR 0.54; 95% CI: 0.39–0.74). Omentoplasty reduced the risk of postoperative infection in thoracic (RR 0.38; 95% CI: 0.18–0.78) and liver surgery (RR 0.39; 95% CI: 0.29–0.52). In patients undergoing esophageal (RR 0.89; 95% CI: 0.80–0.99) and gastrointestinal (RR 0.28; 95% CI: 0.23–0.34) surgery with a BMI greater than 25, omentoplasty is significantly associated with a reduced risk of overall complications compared to patients with normal BMI. No significant differences were found in pelvi-perineal surgery, except infection in patients whose BMI ranged from 25 kg/m2 to 29.9 kg/m2 (RR 1.25; 95% CI: 1.04–1.50) and anastomotic leakage in patients aged over 60 (RR 0.59; 95% CI: 0.39–0.91). Conclusion: Omentoplasty can effectively prevent postoperative infection. It is associated with a lower incidence of multiple postoperative complications in gastrointestinal and liver surgery.
- 4 March 2024
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (6) , 3778-3794
Open AccessThe effect of omentoplasty in various surgical operations: systematic review and meta-analysis
Background: Omentoplasty is commonly used in various surgeries. However, its effectiveness is unsure due to lack of convincing data and research. To clarify the impact of omentoplasty on postoperative complications of various procedures, this systematic review and meta-analysis was performed. Methods: A systematic review of published literatures from four databases: PubMed, Web of Science, Cochrane Library, and Embase before 14 July 2022. The authors primarily included publications on five major surgical operations performed in conjunction with omentoplasty: thoracic surgery, esophageal surgery, gastrointestinal surgery, pelvi-perineal surgery, and liver surgery. The protocol was registered in PROSPERO. Results: This review included 25 273 patients from 91 studies (n=9670 underwent omentoplasty). Omentoplasty was associated with a lower risk of overall complications particularly in gastrointestinal [relative risk (RR) 0.53; 95% CI: 0.39–0.72] and liver surgery (RR 0.54; 95% CI: 0.39–0.74). Omentoplasty reduced the risk of postoperative infection in thoracic (RR 0.38; 95% CI: 0.18–0.78) and liver surgery (RR 0.39; 95% CI: 0.29–0.52). In patients undergoing esophageal (RR 0.89; 95% CI: 0.80–0.99) and gastrointestinal (RR 0.28; 95% CI: 0.23–0.34) surgery with a BMI greater than 25, omentoplasty is significantly associated with a reduced risk of overall complications compared to patients with normal BMI. No significant differences were found in pelvi-perineal surgery, except infection in patients whose BMI ranged from 25 kg/m2 to 29.9 kg/m2 (RR 1.25; 95% CI: 1.04–1.50) and anastomotic leakage in patients aged over 60 (RR 0.59; 95% CI: 0.39–0.91). Conclusion: Omentoplasty can effectively prevent postoperative infection. It is associated with a lower incidence of multiple postoperative complications in gastrointestinal and liver surgery.